275 related articles for article (PubMed ID: 30992000)
21. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
McWilliams JM; Zaslavsky AM; Huskamp HA
JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
[TBL] [Abstract][Full Text] [Related]
22. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
[TBL] [Abstract][Full Text] [Related]
23. Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
Urmie JM; Farris KB; Doucette WR; Goedken AM
J Am Pharm Assoc (2003); 2011; 51(1):72-81. PubMed ID: 21247829
[TBL] [Abstract][Full Text] [Related]
24. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
25. Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.
Alexander GC; Schiman C; Kaestner R
Med Care Res Rev; 2018 Apr; 75(2):153-174. PubMed ID: 29148319
[TBL] [Abstract][Full Text] [Related]
26. Racial and ethnic differences in drug expenditures and access under Medicare Part D.
Chen J; Rizzo JA; Ortega AN
J Health Care Poor Underserved; 2011 Aug; 22(3):1059-74. PubMed ID: 21841296
[TBL] [Abstract][Full Text] [Related]
27. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
28. Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.
Ettner SL; Steers WN; Turk N; Quiter ES; Mangione CM
J Gen Intern Med; 2011 Oct; 26(10):1195-200. PubMed ID: 21710313
[TBL] [Abstract][Full Text] [Related]
29. The Medicare Part D Coverage Gap, Prescription Use, and Expenditures.
Unuigbe A
Med Care Res Rev; 2020 Oct; 77(5):442-450. PubMed ID: 30336732
[TBL] [Abstract][Full Text] [Related]
30. Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket Cap.
Trish E; Xu J; Joyce G
Health Aff (Millwood); 2018 Jul; 37(7):1048-1056. PubMed ID: 29985706
[TBL] [Abstract][Full Text] [Related]
31. Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015.
Watanabe JH; Chau DL; Hirsch JD
J Am Geriatr Soc; 2018 Aug; 66(8):1621-1624. PubMed ID: 29972589
[TBL] [Abstract][Full Text] [Related]
32. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
Look KA; Arora P
Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
[TBL] [Abstract][Full Text] [Related]
33. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
34. Trends in Total and Out-of-Pocket Expenditures for Visits to Primary Care Physicians, by Insurance Type, 2002-2017.
Johansen ME; Yun JDY
Ann Fam Med; 2020 Sep; 18(5):430-437. PubMed ID: 32928759
[TBL] [Abstract][Full Text] [Related]
35. Out-of-Pocket Spending and Premium Contributions After Implementation of the Affordable Care Act.
Goldman AL; Woolhandler S; Himmelstein DU; Bor DH; McCormick D
JAMA Intern Med; 2018 Mar; 178(3):347-355. PubMed ID: 29356828
[TBL] [Abstract][Full Text] [Related]
36. Coverage for hepatitis C drugs in Medicare Part D.
Jung JK; Feldman R; Cheong C; Du P; Leslie D
Am J Manag Care; 2016 May; 22(6 Spec No.):SP220-6. PubMed ID: 27266952
[TBL] [Abstract][Full Text] [Related]
37. Medicare Part D is associated with reducing the financial burden of health care services in Medicare beneficiaries with diagnosed diabetes.
Li R; Gregg EW; Barker LE; Zhang P; Zhang F; Zhuo X; Williams DE; Soumerai SB
Med Care; 2013 Oct; 51(10):888-93. PubMed ID: 23969594
[TBL] [Abstract][Full Text] [Related]
38. Adequacy of Prescription Drug Coverage in Long-term Care.
Briesacher B; Oliveri-Mui B; Chhabra B; Koethe B
Med Care; 2020 May; 58(5):427-432. PubMed ID: 31985585
[TBL] [Abstract][Full Text] [Related]
39. Impact of drug coverage on medical expenditures among the elderly.
Gilman BH; Gage B; Haber S; Hoover S; Aggarwal J
Health Care Financ Rev; 2007; 29(1):103-18. PubMed ID: 18624083
[TBL] [Abstract][Full Text] [Related]
40. The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias.
Lin PJ; Biddle AK; Ganguly R; Kaufer DI; Maciejewski ML
Med Care; 2009 Nov; 47(11):1174-9. PubMed ID: 19786913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
